We classified the top 33% of primary breast tumors regarding their high expression of both ZEB1 mRNA and EPB41L5 mRNA as the high-expression group, and found that ~15% of tumors of the high-expression group bear TP53 mutations (Figure 4e). This evidence concerns the gene ZEB1 and breast neoplasm.